| pubmed-article:18448176 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18448176 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18448176 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:18448176 | lifeskim:mentions | umls-concept:C0206754 | lld:lifeskim |
| pubmed-article:18448176 | lifeskim:mentions | umls-concept:C0055637 | lld:lifeskim |
| pubmed-article:18448176 | lifeskim:mentions | umls-concept:C0242485 | lld:lifeskim |
| pubmed-article:18448176 | pubmed:issue | 1-3 | lld:pubmed |
| pubmed-article:18448176 | pubmed:dateCreated | 2008-6-2 | lld:pubmed |
| pubmed-article:18448176 | pubmed:abstractText | Chromogranin (Cg) and secretogranin (Sg) are members of the granin family of proteins, which are expressed in neuroendocrine and nervous tissue. In recent publications we have presented generation of region-specific antibodies against CgA and CgB and also development of several region-specific radioimmunoassays for measurements of specific parts of the Cgs. In this study we describe generation of antibodies against SgII, SgIII, SgV and the proconvertases PC1/3 and PC2 and development of radioimmunoassays for measurements of these proteins. | lld:pubmed |
| pubmed-article:18448176 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18448176 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18448176 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18448176 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18448176 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18448176 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18448176 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18448176 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18448176 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18448176 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18448176 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18448176 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18448176 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18448176 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:18448176 | pubmed:issn | 0167-0115 | lld:pubmed |
| pubmed-article:18448176 | pubmed:author | pubmed-author:StridsbergMat... | lld:pubmed |
| pubmed-article:18448176 | pubmed:author | pubmed-author:ErikssonBarbr... | lld:pubmed |
| pubmed-article:18448176 | pubmed:author | pubmed-author:JansonEva... | lld:pubmed |
| pubmed-article:18448176 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18448176 | pubmed:day | 5 | lld:pubmed |
| pubmed-article:18448176 | pubmed:volume | 148 | lld:pubmed |
| pubmed-article:18448176 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18448176 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18448176 | pubmed:pagination | 95-8 | lld:pubmed |
| pubmed-article:18448176 | pubmed:meshHeading | pubmed-meshheading:18448176... | lld:pubmed |
| pubmed-article:18448176 | pubmed:meshHeading | pubmed-meshheading:18448176... | lld:pubmed |
| pubmed-article:18448176 | pubmed:meshHeading | pubmed-meshheading:18448176... | lld:pubmed |
| pubmed-article:18448176 | pubmed:meshHeading | pubmed-meshheading:18448176... | lld:pubmed |
| pubmed-article:18448176 | pubmed:meshHeading | pubmed-meshheading:18448176... | lld:pubmed |
| pubmed-article:18448176 | pubmed:meshHeading | pubmed-meshheading:18448176... | lld:pubmed |
| pubmed-article:18448176 | pubmed:meshHeading | pubmed-meshheading:18448176... | lld:pubmed |
| pubmed-article:18448176 | pubmed:meshHeading | pubmed-meshheading:18448176... | lld:pubmed |
| pubmed-article:18448176 | pubmed:meshHeading | pubmed-meshheading:18448176... | lld:pubmed |
| pubmed-article:18448176 | pubmed:meshHeading | pubmed-meshheading:18448176... | lld:pubmed |
| pubmed-article:18448176 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18448176 | pubmed:articleTitle | Measurements of secretogranins II, III, V and proconvertases 1/3 and 2 in plasma from patients with neuroendocrine tumours. | lld:pubmed |
| pubmed-article:18448176 | pubmed:affiliation | Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden. mats.stridsberg@akademiska.se | lld:pubmed |
| pubmed-article:18448176 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18448176 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:6447 | entrezgene:pubmed | pubmed-article:18448176 | lld:entrezgene |
| entrez-gene:7857 | entrezgene:pubmed | pubmed-article:18448176 | lld:entrezgene |
| entrez-gene:29106 | entrezgene:pubmed | pubmed-article:18448176 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:18448176 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:18448176 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:18448176 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18448176 | lld:pubmed |
